NPI: 1467706416 · HARTSVILLE, SC 29550 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/30/2012
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 10/30/2012 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 626 | $5K |
| 2019 | 290 | $301.78 |
| 2020 | 2,180 | $2K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90935 | Hemodialysis procedure with single evaluation by a physician | 2,062 | 217 | $6K |
| A4657 | Syringe, with or without needle, each | 698 | 313 | $1K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 19 | 13 | $259.47 |
| 83970 | 43 | 36 | $51.16 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 54 | 24 | $33.92 |
| 82728 | 30 | 25 | $23.78 | |
| 83540 | 29 | 25 | $18.87 | |
| 83550 | 29 | 25 | $17.50 | |
| 85048 | 57 | 49 | $9.54 | |
| 85041 | 57 | 49 | $7.76 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 18 | 12 | $0.00 |